Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Esophagus 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × perfluorobutane × Clear all
NCT03578224 2025-05-18

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
35 enrolled
Gastrointestinal

Esophagus

NCT02652923 2023-01-23

Contrast Ultrasound Detection of Sentinel Lymph Nodes

Thomas Jefferson University

Phase 1/2 Completed
98 enrolled
Breast

Breast Neoplasms

NCT05068076 2021-12-21

Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

Institute of Liver and Biliary Sciences, India

Phase NA Completed
21 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡